GB8501889D0 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number: GB8501889D0
Authority: GB; United Kingdom
Prior art keywords: heterocyclic compounds; heterocyclic; compounds
Prior art date: 1984-01-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

GB858501889A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-25

Filing date

1985-01-25

Publication date

1985-02-27

1984-01-25 Priority claimed from GB848401888A external-priority patent/GB8401888D0/en

1984-10-15 Priority claimed from GB848425959A external-priority patent/GB8425959D0/en

1985-01-25 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1985-02-27 Publication of GB8501889D0 publication Critical patent/GB8501889D0/en

1985-08-29 Publication of GB2153821A publication Critical patent/GB2153821A/en

1988-01-20 Application granted granted Critical

1988-01-20 Publication of GB2153821B publication Critical patent/GB2153821B/en

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

GB08501889A 1984-01-25 1985-01-25 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives Expired GB2153821B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB848401888A GB8401888D0 (en)	1984-01-25	1984-01-25	Heterocyclic compounds
GB848425959A GB8425959D0 (en)	1984-10-15	1984-10-15	Heterocyclic compounds

Publications (3)

Publication Number	Publication Date
GB8501889D0 true GB8501889D0 (en)	1985-02-27
GB2153821A GB2153821A (en)	1985-08-29
GB2153821B GB2153821B (en)	1988-01-20

Family

ID=26287221

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB08501889A Expired GB2153821B (en)	1984-01-25	1985-01-25	3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives

Country Status (29)

Country	Link
KR (1)	KR920003064B1 (en)
AT (1)	AT392276B (en)
AU (1)	AU579132B2 (en)
BE (1)	BE901576A (en)
CA (1)	CA1252793A (en)
CH (1)	CH664152A5 (en)
CY (1)	CY1479A (en)
CZ (1)	CZ404391A3 (en)
DE (2)	DE3502508A1 (en)
DK (1)	DK169521B1 (en)
ES (3)	ES8609309A1 (en)
FI (1)	FI84349C (en)
FR (1)	FR2561244B1 (en)
GB (1)	GB2153821B (en)
GR (1)	GR850219B (en)
HK (1)	HK33189A (en)
HU (1)	HU193592B (en)
IE (1)	IE57809B1 (en)
IL (1)	IL74165A (en)
IT (1)	IT1182150B (en)
LU (2)	LU88268I2 (en)
NL (2)	NL190373C (en)
NO (2)	NO164025C (en)
NZ (1)	NZ210940A (en)
PH (1)	PH22672A (en)
PT (1)	PT79890B (en)
SE (1)	SE460359B (en)
SG (1)	SG7089G (en)
SK (1)	SK277923B6 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470868A (en)	1991-06-26	1995-11-28	Sepracor Inc.	Methods for treating emesis and nausea using optically pure R(+) ondansetron
CN115611864A (en) *	2022-11-01	2023-01-17	常州兰陵制药有限公司	A kind of ondansetron compound and its preparation method and application

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4695578A (en) *	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3680123D1 (en) *	1985-01-23	1991-08-14	Glaxo Group Ltd	Tetrahydrocarbazolonderivate.
DE3689974T2 (en) *	1985-03-14	1994-11-03	Beecham Group Plc	Medicines to treat emesis.
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
US5578628A (en) *	1985-06-25	1996-11-26	Glaxo Group Limited	Medicaments for the treatment of nausea and vomiting
GB8518742D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Process
US5204356A (en) *	1985-07-24	1993-04-20	Glaxo Group Limited	Treatment of anxiety
GB8518658D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Medicaments
GB8518741D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Process
GB8518743D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Heterocyclic compounds
GB8518745D0 (en)	1985-07-24	1985-08-29	Glaxo Group Ltd	Heterocyclic compounds
GB8617994D0 (en) *	1986-07-23	1986-08-28	Glaxo Group Ltd	Heterocyclic compounds
NL8701682A (en) *	1986-07-30	1988-02-16	Sandoz Ag	METHOD FOR THE THERAPEUTIC USE OF SEROTONIN ANTAGONISTS, ACTIVE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
AT396870B (en) *	1986-08-07	1993-12-27	Sandoz Ag	Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
GB8623819D0 (en) *	1986-10-03	1986-11-05	Glaxo Group Ltd	Heterocyclic compounds
DE3777805D1 (en) *	1986-11-21	1992-04-30	Glaxo Group Ltd	MEDICINES FOR TREATING OR PREVENTING THE WITHDRAWAL SYNDROME.
GB8627909D0 (en) *	1986-11-21	1986-12-31	Glaxo Group Ltd	Medicaments
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
GB8812002D0 (en) *	1988-05-20	1988-06-22	Glaxo Group Ltd	Chemical compounds
US5202343A (en) *	1986-11-28	1993-04-13	Glaxo Group Limited	Tricyclic ketones useful as HT3 -receptor antagonists
GB8628475D0 (en) *	1986-11-28	1987-01-07	Glaxo Group Ltd	Medicaments
US4973594A (en) *	1986-12-17	1990-11-27	Glaxo Group Limited	Medicaments
US5200414A (en) *	1986-12-17	1993-04-06	Glaxo Group Limited	Methods for the treatment of cognitive disorders
ES2052585T3 (en) *	1986-12-17	1994-07-16	Glaxo Group Ltd	USE OF KETONIC DERIVATIVES IN THE TREATMENT OF COGNITIVE DISORDERS.
US5190954A (en) *	1986-12-17	1993-03-02	Glaxo Group Limited	Methods for the treatment of cognitive disorders
GB8630071D0 (en) *	1986-12-17	1987-01-28	Glaxo Group Ltd	Medicaments
GB8630079D0 (en) *	1986-12-17	1987-01-28	Glaxo Group Ltd	Medicaments
EP0291172B1 (en) *	1987-04-14	1992-11-19	Glaxo Group Limited	Ketone derivatives
DE3874229T2 (en) *	1987-06-16	1993-03-25	British Tech Group	USE OF DIOXOPIPERIDINE DERIVATIVES FOR PRODUCING A TOPICAL PREPARATION AS AN ANALGETIC.
DE3822792C2 (en) *	1987-07-11	1997-11-27	Sandoz Ag	New use of 5HT¶3¶ antagonists
GB8723157D0 (en) *	1987-10-02	1987-11-04	Beecham Group Plc	Compounds
JPH01258673A (en) *	1987-10-22	1989-10-16	Glaxo Group Ltd	Ketone derivative
CA1304082C (en) *	1987-10-22	1992-06-23	Tetsuya Tahara	Benzoxazine compounds and pharmaceutical use thereof
US5225431A (en) *	1987-10-23	1993-07-06	Burroughs Wellcome Co.	Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) *	1988-03-04	1988-04-07	Glaxo Group Ltd	Medicaments
JPH0249772A (en) *	1988-04-07	1990-02-20	Glaxo Group Ltd	Imidazole derivative
DK185489A (en) *	1988-04-22	1989-10-23	Duphar Int Res	IMIDAZOLYLMETHYL-CYCLOALKANOEBAA INDOLONES, THEIR PREPARATION AND USE
EP0339959A3 (en) *	1988-04-27	1991-03-20	Glaxo Group Limited	Lactam derivatives
GB8812636D0 (en) *	1988-05-27	1988-06-29	Glaxo Group Ltd	Chemical compounds
US5290785A (en) *	1988-09-27	1994-03-01	Fujisawa Pharmaceutical Co., Ltd.	Therapeutic agent for ischemic diseases
US5173493A (en) *	1988-09-27	1992-12-22	Fujisawa Pharmaceutical Company, Ltd.	Pyridoindole derivatives and processes for preparation thereof
AU627221B2 (en) *	1988-09-27	1992-08-20	Fujisawa Pharmaceutical Co., Ltd.	Pyridoindole derivatives and processes for preparation thereof
FR2639944B1 (en) *	1988-12-06	1991-01-18	Adir	NEW INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2004911A1 (en) *	1988-12-22	1990-06-22	Mitsuaki Ohta	4,5,6,7-tetrahydrobenzimidazole derivatives
EP0377238A1 (en) *	1988-12-22	1990-07-11	Duphar International Research B.V	New annelated indolo (3,2-c)-lactams
US5223625A (en) *	1988-12-22	1993-06-29	Duphar International Research B.V.	Annelated indolo [3,2,-C]lactams
KR900013959A (en) *	1989-03-13	1990-10-22	원본미기재	γ-carbline or their pharmaceutically acceptable acid addition salts and / or hydrates, and pharmaceutical compositions composed thereof
JPH0669963B2 (en) *	1989-04-21	1994-09-07	サンド・アクチエンゲゼルシャフト	5HT-Bottom 3 Therapeutic use of receptor antagonists
GB8914804D0 (en) *	1989-06-28	1989-08-16	Glaxo Group Ltd	Process
GB8917557D0 (en) *	1989-08-01	1989-09-13	Glaxo Group Ltd	Medicaments
US5276050A (en) *	1989-08-01	1994-01-04	Glaxo Group Limited	Medicaments
US5126343A (en) *	1989-09-11	1992-06-30	G. D. Searle & Co.	N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en)	1989-10-14	1993-04-28	Wyeth John & Brother Ltd	Heterocyclic compounds
GB8928837D0 (en) *	1989-12-21	1990-02-28	Beecham Group Plc	Pharmaceuticals
US5187166A (en) *	1990-07-31	1993-02-16	Nisshin Flour Milling Co., Ltd.	Azabicyclo derivatives and their use as antiemetics
JPH05310732A (en) *	1992-03-12	1993-11-22	Mitsubishi Kasei Corp	Cinnoline-3-carboxylic acid derivative
ES2043535B1 (en) *	1992-03-13	1994-08-01	Vita Invest Sa	PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
HU212934B (en)	1992-10-14	1996-12-30	Richter Gedeon Vegyeszet	Process for producing novel alkoxalylated carbazolone derivatives
CA2106642C (en) *	1992-10-14	2005-08-16	Peter Bod	Carbazolone derivatives and process for preparing the same
HUT68293A (en) *	1993-03-08	1995-06-28	Fujisawa Pharmaceutical Co	5-ht antagonists as acting agent against cerebrovascular deseases
GB9310756D0 (en) *	1993-05-25	1993-07-14	Glaxo Lab Sa	Compositions
GB2327348A (en) *	1994-06-28	1999-01-27	Kenneth Francis Prendergast	Pharmaceutical use of ondansetron
GB9423588D0 (en) *	1994-11-22	1995-01-11	Glaxo Wellcome Inc	Compositions
US6365743B1 (en)	1995-10-13	2002-04-02	Duphar International Research B.V.	Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) *	1995-10-13	1999-02-25	Duphar International Research B.V.	Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) *	1996-09-19	1999-10-19	Virginia Commonwealth University	Benzylamidine derivatives with serotonin receptor binding activity
EP1181015A2 (en)	1999-03-01	2002-02-27	Sepracor Inc.	Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
EP1207160A1 (en) *	2000-11-20	2002-05-22	Hanmi Pharm. Co., Ltd.	Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
ATE364611T1 (en)	2002-04-29	2007-07-15	Teva Gyogyszergyar Zartkoeruee	METHOD FOR PRODUCING 1,2,3,9-TETRAHYDRO-9-METHYL-3-(2-METHYL-1H-IMIDAZOL-1-YL)METHYLÖ-H-CARBAZOL-4-ONE
FI6164U1 (en) *	2003-01-09	2004-03-15	Synthon Bv	Ondansetronformer
GB2398071B (en) *	2003-01-24	2006-06-07	Synthon Bv	Process for making ondansetron and intermediate thereof
ES2238001B1 (en) *	2004-01-21	2006-11-01	Vita Cientifica, S.L.	NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS.
CA2565854A1 (en)	2004-05-07	2005-11-17	Taro Pharmaceutical Industries Ltd.	Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20090170872A1 (en) *	2005-07-05	2009-07-02	Orchid Research Laboratories Limited	Compounds and Their Pharmaceutical Use
SI2432467T1 (en)	2009-05-20	2018-06-29	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
ES2432618T3 (en)	2009-05-20	2013-12-04	Inserm (Institut National De La Santé Et De La Recherche Medicale)	Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of a pathology of the inner ear with vestibular deficit
GB202301322D0 (en)	2023-01-30	2023-03-15	Therakind Ltd	Antiemetic pharmaceutical compositions for nasal delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3634420A (en) *	1969-05-09	1972-01-11	American Cyanamid Co	3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
US3740404A (en) *	1969-05-09	1973-06-19	American Cyanamid Co	Piperidinomethylenedihydrocarbazolones
DE3680123D1 (en) *	1985-01-23	1991-08-14	Glaxo Group Ltd	Tetrahydrocarbazolonderivate.

1985
- 1985-01-25 NZ NZ210940A patent/NZ210940A/en unknown
- 1985-01-25 BE BE0/214394A patent/BE901576A/en not_active IP Right Cessation
- 1985-01-25 FR FR8501056A patent/FR2561244B1/en not_active Expired
- 1985-01-25 DE DE19853502508 patent/DE3502508A1/en active Granted
- 1985-01-25 GR GR850219A patent/GR850219B/el active IP Right Revival
- 1985-01-25 AT AT204/85A patent/AT392276B/en not_active IP Right Cessation
- 1985-01-25 CH CH346/85A patent/CH664152A5/en not_active IP Right Cessation
- 1985-01-25 LU LU88268C patent/LU88268I2/xx unknown
- 1985-01-25 DE DE1993175046 patent/DE19375046I2/en active Active
- 1985-01-25 CA CA000472888A patent/CA1252793A/en not_active Expired
- 1985-01-25 FI FI850323A patent/FI84349C/en not_active IP Right Cessation
- 1985-01-25 NL NLAANVRAGE8500202,A patent/NL190373C/en not_active IP Right Cessation
- 1985-01-25 LU LU85743A patent/LU85743A1/en active Protection Beyond IP Right Term
- 1985-01-25 IT IT47600/85A patent/IT1182150B/en active Protection Beyond IP Right Term
- 1985-01-25 IE IE187/85A patent/IE57809B1/en not_active IP Right Cessation
- 1985-01-25 NO NO850300A patent/NO164025C/en not_active IP Right Cessation
- 1985-01-25 DK DK035785A patent/DK169521B1/en not_active IP Right Cessation
- 1985-01-25 IL IL74165A patent/IL74165A/en not_active IP Right Cessation
- 1985-01-25 PT PT79890A patent/PT79890B/en unknown
- 1985-01-25 GB GB08501889A patent/GB2153821B/en not_active Expired
- 1985-01-25 PH PH31770A patent/PH22672A/en unknown
- 1985-01-25 HU HU85296A patent/HU193592B/en unknown
- 1985-01-25 KR KR1019850000454A patent/KR920003064B1/en not_active IP Right Cessation
- 1985-01-25 ES ES539852A patent/ES8609309A1/en not_active Expired
- 1985-01-25 AU AU38097/85A patent/AU579132B2/en not_active Expired
- 1985-01-25 SE SE8500368A patent/SE460359B/en not_active IP Right Cessation
- 1985-10-31 ES ES548430A patent/ES8708224A1/en not_active Expired
1986
- 1986-06-16 ES ES556101A patent/ES8801247A1/en not_active Expired
1989
- 1989-02-09 SG SG70/89A patent/SG7089G/en unknown
- 1989-04-20 HK HK331/89A patent/HK33189A/en not_active IP Right Cessation
- 1989-07-21 CY CY1479A patent/CY1479A/en unknown
1991
- 1991-12-23 CZ CS914043A patent/CZ404391A3/en unknown
- 1991-12-23 SK SK4043-91A patent/SK277923B6/en unknown
1994
- 1994-05-31 NL NL940009C patent/NL940009I2/en unknown
- 1994-11-09 NO NO1994022C patent/NO1994022I1/en unknown

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470868A (en)	1991-06-26	1995-11-28	Sepracor Inc.	Methods for treating emesis and nausea using optically pure R(+) ondansetron
US5629333A (en)	1991-06-26	1997-05-13	Sepracor Inc.	Method treating cognitive disorders using optically pure R(+) ondansetron
US5712302A (en)	1991-06-26	1998-01-27	Sepracor Inc.	Compositions using optically pure R(+) ondansetron
US5962494A (en)	1991-06-26	1999-10-05	Sepracor Inc.	Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
CN115611864A (en) *	2022-11-01	2023-01-17	常州兰陵制药有限公司	A kind of ondansetron compound and its preparation method and application

Also Published As

Publication number	Publication date
AU3809785A (en)	1985-08-01
CH664152A5 (en)	1988-02-15
HUT37784A (en)	1986-02-28
IT1182150B (en)	1987-09-30
LU85743A1 (en)	1986-08-04
PH22672A (en)	1988-11-14
NZ210940A (en)	1989-08-29
ES8801247A1 (en)	1987-12-16
AU579132B2 (en)	1988-11-17
BE901576A (en)	1985-07-25
FI84349C (en)	1991-11-25
NL8500202A (en)	1985-08-16
ES8708224A1 (en)	1987-10-01
FR2561244B1 (en)	1988-03-04
NL940009I2 (en)	1999-05-03
NL940009I1 (en)	1994-07-18
SE8500368L (en)	1985-07-26
KR920003064B1 (en)	1992-04-13
DE19375046I2 (en)	2002-10-10
SG7089G (en)	1989-06-09
SE8500368D0 (en)	1985-01-25
ES539852A0 (en)	1986-07-16
GR850219B (en)	1985-05-23
ES8609309A1 (en)	1986-07-16
FI850323L (en)	1985-07-26
ATA20485A (en)	1990-08-15
NL190373B (en)	1993-09-01
HK33189A (en)	1989-04-28
NO164025C (en)	1990-08-22
AT392276B (en)	1991-02-25
SK404391A3 (en)	1995-08-09
PT79890B (en)	1987-02-03
CY1479A (en)	1989-07-21
NO164025B (en)	1990-05-14
ES556101A0 (en)	1987-12-16
DE3502508A1 (en)	1985-08-14
SE460359B (en)	1989-10-02
CZ404391A3 (en)	1993-04-14
SK277923B6 (en)	1995-08-09
DK169521B1 (en)	1994-11-21
IL74165A (en)	1988-11-15
DK35785A (en)	1985-07-26
ES548430A0 (en)	1987-10-01
DK35785D0 (en)	1985-01-25
FI850323A0 (en)	1985-01-25
GB2153821A (en)	1985-08-29
NO850300L (en)	1985-07-26
FR2561244A1 (en)	1985-09-20
CA1252793A (en)	1989-04-18
GB2153821B (en)	1988-01-20
FI84349B (en)	1991-08-15
PT79890A (en)	1985-02-01
NL190373C (en)	1994-02-01
DE3502508C2 (en)	1990-05-03
IE850187L (en)	1985-07-25
HU193592B (en)	1987-11-30
KR850005439A (en)	1985-08-26
LU88268I2 (en)	1994-02-03
IT8547600A0 (en)	1985-01-25
IE57809B1 (en)	1993-04-21
NO1994022I1 (en)	1994-11-09

Publication	Publication Date	Title
GB8501889D0 (en)	1985-02-27	Heterocyclic compounds
EP0182054A3 (en)	1987-04-22	Heterocyclic compounds
GB8505662D0 (en)	1985-04-03	Heterocyclic compounds
EG17800A (en)	1990-08-30	Heterocyclic compounds
GB8405368D0 (en)	1984-04-04	Heterocyclic compounds
GB8412750D0 (en)	1984-06-27	Heterocyclic compounds
GB8516434D0 (en)	1985-07-31	Heterocyclic compounds
GB8408615D0 (en)	1984-05-16	Heterocyclic compounds
EP0181145A3 (en)	1986-12-30	Heterocyclic compounds
GB8504630D0 (en)	1985-03-27	Heterocyclic compounds
GB8421039D0 (en)	1984-09-19	Heterocyclic compounds
GB8425969D0 (en)	1984-11-21	Heterocyclic compounds
GB8401888D0 (en)	1984-02-29	Heterocyclic compounds
GB8515749D0 (en)	1985-07-24	Heterocyclic compounds
GB8429128D0 (en)	1984-12-27	Heterocyclic compounds
GB8427152D0 (en)	1984-12-05	Heterocyclic compounds
GB8430020D0 (en)	1985-01-09	Heterocyclic compounds
GB8420355D0 (en)	1984-09-12	Heterocyclic compounds
GB8414787D0 (en)	1984-07-11	Heterocyclic compounds
GB8424607D0 (en)	1984-11-07	Heterocyclic compounds
GB8425959D0 (en)	1984-11-21	Heterocyclic compounds
GB8414202D0 (en)	1984-07-11	Heterocyclic compounds
GB8412182D0 (en)	1984-06-20	Heterocyclic compounds
GB8427687D0 (en)	1984-12-05	Heterocyclic compounds
GB8427688D0 (en)	1984-12-05	Heterocyclic compounds

Legal Events

Date	Code	Title	Description
1993-07-28	CTFF	Supplementary protection certificate filed	Free format text: SPC/GB93/072, 930617
1993-10-27	CTFA	Application for supplementary protection certificate granted	Free format text: SPC/GB93/072, 931005, EXPIRES:20050222
2005-02-16	CTFE	Supplementary protection certificate entered into force	Free format text: SPC/GB93/072: 20050125, EXPIRES: 20050222 Spc suppl protection certif: SPC/GB93/072 Filing date: 20050125 Expiry date: 20050222
2005-02-16	PE20	Patent expired after termination of 20 years	Effective date: 20050124
2005-03-16	SPCE	Supplementary protection certificate expired	Free format text: SPC/GB93/072, EXPIRES: 20050222 Spc suppl protection certif: SPC/GB93/072 Expiry date: 20050222
2006-04-12	740F	Application filed by employee for compensation - according to sect. 40
2007-05-09	740F	Application filed by employee for compensation - according to sect. 40